Phase 2 Anatomic Stage II Breast Cancer AJCC v8 trials recruiting now

All Anatomic Stage II Breast Cancer AJCC v8 trials, every phase

Other phases for Anatomic Stage II Breast Cancer AJCC v8

Phase 2 Anatomic Stage II Breast Cancer AJCC v8 trials

• 5-strain Probiotic Formulation in HR-positive Breast Cancer Receiving Aromatase Inhibitor to Prevent Bone Loss
  NCT07044310 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
• Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer
  NCT04329065 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Dose-Reduced Docetaxel With Cyclophosphamide for the Treatment of Vulnerable Older Women With Stage I-III HER2 Negative Breast Cancer, the DOROTHY Trial
  NCT06042569 · Phase: Phase 2 · Ages: 65 Years and older · Sex: All (male and female) · 3 locations
• Evaluation of Alternative Site Goserelin Acetate Injection for Ovarian Function Suppression (OFS) in Local and Locally Advanced Premenopausal Hormone Receptor Positive Breast Cancer Patients
  NCT07460752 · Phase: Phase 2 · Ages: 18 Years to 50 Years · Sex: Female · 1 location
• Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors
  NCT05595499 · Phase: Phase 2 · Ages: No age limits stated · Sex: Female · 7 locations
• Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer
  NCT06635980 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
• Imlunestrant and Abemaciclib for the Treatment of Estrogen Receptor Positive Breast Cancer in Patients With Minimal Residual Disease, MIRI Trial
  NCT07191717 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Leuprolide and Goserelin for Ovarian Function Suppression in Pre- or Peri-menopausal Women With Breast Cancer, OFS Trial
  NCT07158021 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
• Neoadjuvant Darolutamide Alone or in Combination With Standard Therapy for Stage II-IIIA, AR+, TNBC
  NCT07016399 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Ph2 Study for Optimization of Adjunct Systemic Therapy in HER2+ Patients, MolecularPCR Trial
  NCT07407920 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Prevention of Frailty With Fisetin and Exercise in Breast Cancer Survivors
  NCT06113016 · Phase: Phase 2 · Ages: No age limits stated · Sex: Female · 6 locations
• Ultra-hypofractionated Whole Breast Irradiation With Lumpectomy Cavity Boost for the Treatment of Stage I-III Breast Cancer
  NCT06954831 · Phase: Phase 2 · Ages: 40 Years and older · Sex: Female · 7 locations

Common questions

What does Phase 2 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.